NASDAQ Small Stocks in News (RSCR, AUTH, IDIX)

Res-Care, Inc. (NASDAQ:RSCR) shares jumped 6.50% to $13.25 after Onex Partners III, L.P. reached an agreement with Res-Care to acquire the later for r $13.25 a share in all cash deal. The deal price represents a premium of 30.7% premium to the closing price on August 13, 2010, the last trading day before Onex made its initial proposal.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.PennyStockPickReport.com

Res-Care, Inc. (ResCare) is a human service company that provides residential, therapeutic, job training and educational supports to people with developmental or other disabilities, to youth with special needs, to adults who are experiencing barriers to employment and to older people who need home care assistance.

AuthenTec, Inc. (NASDAQ:AUTH) rose 5.06% to $1.85 after the company and privately-held UPEK announced Tuesday that the companies have combined, creating the world's largest provider of fingerprint sensors and identity management software, as well as biometric and embedded security solutions.

AuthenTec will remain headquartered in Melbourne, Florida and will be led by newly named CEO Larry Ciaccia, who previously served as AuthenTec's President and Chief Operating Officer. The combined company is expected to generate in excess of $10.0 million in cost synergies in 2011.

AuthenTec, Inc. (AuthenTec) is a provider of security, identity management and touch control technologies for personal computer (PC), wireless device and information technology (IT) markets. The Company provides a series of products, including fingerprint sensors, software and intellectual property (IP) cores.

Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) shares plunged 47.25% to $3.16 after the company said that the U.S. Food and Drug Administration (FDA) has sent an notice to the company to put their IDX184 and IDX320 programs on clinical hold.

A clinical hold is an order issued by the FDA to the sponsor to delay a proposed clinical investigation or to suspend an ongoing investigation.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.PennyStockPickReport.com

This decision was made after Idenix notified the FDA of three serious adverse events that occurred during a drug-drug interaction study of the combination of IDX184 and IDX320 in healthy volunteers. These observed serious adverse events were elevated liver function tests detected in three subjects during post exposure safety visits.

Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe.

About http://www.PennyStockPickReport.com

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.